Inflammation and Heart Risk in Myelodysplastic Syndromes
Part of Blood & lymphatic clinical trials.
This study looks at whether certain signs of inflammation in the blood can help predict heart problems in people with myelodysplastic syndromes (MDS). If you have MDS and are generally well enough to participate, this trial may help doctors better understand and manage your risk of heart disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a confirmed diagnosis of myelodysplastic syndromes (MDS), a bone marrow condition that affects blood cell production.
- You are able to do most or some daily activities (score 0–3 on a standard health scale).
- Your doctor believes you are likely to live at least 6 months.
- You are not scheduled for a stem cell transplant within the next 6 months.
- You do not have a more advanced type of MDS called 'MDS with excess blasts 2'.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to better monitor and manage heart health in people with multiple myeloma while they start a new treatment plan. It tests a heart risk check-in process with your care team to help catch and address any heart-related issues early.
This study looks at special stem cells in the blood or bone marrow of people with myelodysplastic syndromes (MDS). It aims to better predict how the disease might progress and help guide treatment decisions.
This study looks at whether certain blood test results can help predict how myelodysplastic syndromes (MDS) will progress. It may help doctors better understand your condition and plan your care.
This study looks at whether healthy lifestyle changes (such as diet and exercise) can help people with low-risk Myelodysplastic Syndrome (MDS), a condition where the bone marrow doesn't produce enough healthy blood cells. It may improve anemia and overall well-being.
This study uses repeated blood samples to watch how genetic changes in your blood evolve in lower-risk myelodysplastic syndrome (MDS). It may help doctors understand what mutation changes mean over time for people not on strong cancer-fighting treatments.
This study carefully evaluates people with myelodysplastic syndromes (MDS) and closely related blood disorders using detailed medical, blood, and bone marrow testing. The goal is to better understand these conditions and how they progress, which may help guide future care.
Hear when a new Myelodysplastic Syndromes, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.